"Sulfonic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inorganic or organic oxy acids of sulfur which contain the RSO2(OH) radical.
Descriptor ID |
D013451
|
MeSH Number(s) |
D01.029.260.877.740 D01.875.800.740 D02.886.645.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sulfonic Acids".
Below are MeSH descriptors whose meaning is more specific than "Sulfonic Acids".
This graph shows the total number of publications written about "Sulfonic Acids" by people in this website by year, and whether "Sulfonic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2016 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sulfonic Acids" by people in Profiles.
-
Difference in suitable mechanical properties of three-dimensional, synthetic scaffolds for self-renewing mouse embryonic stem cells of different genetic backgrounds. J Biomed Mater Res B Appl Biomater. 2017 Nov; 105(8):2261-2268.
-
A Simple Pharmacokinetic Model of Prenatal and Postnatal Exposure to Perfluoroalkyl Substances (PFASs). Environ Sci Technol. 2016 Jan 19; 50(2):978-86.
-
Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach. J Med Chem. 2014 Oct 23; 57(20):8340-57.
-
Antitubercular nucleosides that inhibit siderophore biosynthesis: SAR of the glycosyl domain. J Med Chem. 2006 Dec 28; 49(26):7623-35.
-
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis. 2001 Jul; 157(1):137-44.
-
Encephalopathy is the dose-limiting toxicity of intravenous hepsulfam: results of a phase I trial in patients with advanced hematological malignancies. Cancer Chemother Pharmacol. 1995; 36(3):204-10.
-
Anion transport in the Ehrlich ascites tumor cell: the effect of 2,4,6-trinitrobenzene sulfonic acid. J Cell Physiol. 1973 Dec; 82(3):435-44.
-
Selective solubilization of proteins from red blood cell membranes by protein perturbants. J Supramol Struct. 1973; 1(3):220-32.